Free Trial
NASDAQ:ONC

BeOne Medicines (ONC) Stock Price, News & Analysis

BeOne Medicines logo
$299.01 -2.12 (-0.70%)
As of 08/1/2025 04:00 PM Eastern

About BeOne Medicines Stock (NASDAQ:ONC)

Key Stats

Today's Range
$288.07
$299.29
50-Day Range
$238.31
$305.74
52-Week Range
$155.75
$308.87
Volume
543,060 shs
Average Volume
402,877 shs
Market Capitalization
$32.77 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$327.56
Consensus Rating
Buy

Company Overview

BeOne Medicines Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
15th Percentile Overall Score

ONC MarketRank™: 

BeOne Medicines scored higher than 15% of companies evaluated by MarketBeat, and ranked 865th out of 916 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    BeOne Medicines has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 7 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    BeOne Medicines has only been the subject of 4 research reports in the past 90 days.

  • Read more about BeOne Medicines' stock forecast and price target.
  • Earnings Growth

    Earnings for BeOne Medicines are expected to grow in the coming year, from ($5.82) to $0.71 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of BeOne Medicines is -80.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of BeOne Medicines is -80.38, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    BeOne Medicines has a P/B Ratio of 8.77. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

  • Read more about BeOne Medicines' valuation and earnings.
  • Short Interest

    There is no current short interest data available for ONC.
  • Dividend Yield

    BeOne Medicines does not currently pay a dividend.

  • Dividend Growth

    BeOne Medicines does not have a long track record of dividend growth.

  • Short Interest

    There is no current short interest data available for ONC.
  • News Sentiment

    BeOne Medicines has a news sentiment score of 0.42. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 12 news articles for BeOne Medicines this week, compared to 7 articles on an average week.
  • Search Interest

    Only 4 people have searched for ONC on MarketBeat in the last 30 days. This is a decrease of -71% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, BeOne Medicines insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $35,948,388.00 in company stock.

  • Percentage Held by Insiders

    Only 6.62% of the stock of BeOne Medicines is held by insiders.

  • Percentage Held by Institutions

    48.55% of the stock of BeOne Medicines is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about BeOne Medicines' insider trading history.
Receive ONC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for BeOne Medicines and its competitors with MarketBeat's FREE daily newsletter.

ONC Stock News Headlines

Investigating the Most Controversial Stock on Earth
Tesla’s wild price swings may not be random after all. Hedge fund veteran Larry Benedict has uncovered a strange pattern—what he calls the “Tesla Glitch”—that’s wiped out billions without warning… and then sent the stock surging hours later. He now says it ties directly back to the 2010 Flash Crash.
BeOne Medicines' Tevimbra Gets CHMP Positive Opinion
Wall Street Zen Upgrades BeOne Medicines (NASDAQ:ONC) to "Buy"
See More Headlines

ONC Stock Analysis - Frequently Asked Questions

BeOne Medicines' stock was trading at $223.50 at the start of the year. Since then, ONC stock has increased by 33.8% and is now trading at $299.01.

BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) posted its quarterly earnings results on Wednesday, May, 7th. The company reported $1.22 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.71) by $1.93. The business earned $1.12 billion during the quarter, compared to the consensus estimate of $1.12 billion. BeOne Medicines had a negative trailing twelve-month return on equity of 7.55% and a negative net margin of 9.40%.

Top institutional shareholders of BeOne Medicines include Envestnet Asset Management Inc. (0.06%), Twin Tree Management LP, Oppenheimer Asset Management Inc. (0.03%) and Asset Management One Co. Ltd. (0.02%). Insiders that own company stock include Lai Wang, Lai Wang, Bros Advisors Lp Baker, Xiaodong Wang, Xiaobin Wu, Titus B Ball, John Oyler and Chan Henry Lee.
View institutional ownership trends
.

Shares of ONC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
5/07/2025
Today
8/03/2025
Next Earnings (Confirmed)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ONC
Previous Symbol
NASDAQ:ONC
CIK
1651308
Web
N/A
Fax
N/A
Employees
11,000
Year Founded
N/A

Price Target and Rating

High Price Target
$350.00
Low Price Target
$259.00
Potential Upside/Downside
+9.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
7 Analysts

Profitability

EPS (Trailing Twelve Months)
($3.72)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$644.79 million
Net Margins
-9.40%
Pretax Margin
-6.43%
Return on Equity
-7.55%
Return on Assets
-4.42%

Debt

Debt-to-Equity Ratio
0.05
Current Ratio
1.96
Quick Ratio
1.71

Sales & Book Value

Annual Sales
$3.81 billion
Price / Sales
8.60
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$34.10 per share
Price / Book
8.77

Miscellaneous

Outstanding Shares
109,600,000
Free Float
102,344,000
Market Cap
$32.77 billion
Optionable
N/A
Beta
0.27
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

This page (NASDAQ:ONC) was last updated on 8/3/2025 by MarketBeat.com Staff
From Our Partners